CASI Pharmaceuticals Inc.

NASDAQ: CASI · Real-Time Price · USD
1.86
-0.01 (-0.54%)
At close: Jun 06, 2025, 3:53 PM
1.80
-3.32%
After-hours: Jun 06, 2025, 04:24 PM EDT
-0.54%
Bid 1.74
Market Cap 28.85M
Revenue (ttm) 28.54M
Net Income (ttm) -39.26M
EPS (ttm) -2.54
PE Ratio (ttm) -0.73
Forward PE -1.16
Analyst Buy
Ask 1.9
Volume 3,747
Avg. Volume (20D) 9,352
Open 1.89
Previous Close 1.87
Day's Range 1.86 - 1.89
52-Week Range 1.64 - 7.67
Beta 0.63

About CASI

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CASI
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CASI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 months ago
+0.95%
CASI Pharmaceuticals shares are trading higher aft... Unlock content with Pro Subscription
11 months ago
+36.49%
CASI Pharmaceuticals shares are trading higher after the company announced plans to submit an Investigational New Drug application to the FDA for CID-103 for the treatment of antibody-mediated rejection in kidney transplant recipients. Also, the company received a preliminary non-binding proposal letter from CEO and Chairman Wei-Wu He to acquire its business operations in China.